Regulations.gov document
Drug Products Labeled as Homeopathic Guidance for FDA Staff and Industry; Draft Guidance
Other · FDA-2017-D-6580 · posted Oct 25, 2019
Key facts
| Document ID | FDA-2017-D-6580-4829 |
|---|---|
| Title | Drug Products Labeled as Homeopathic Guidance for FDA Staff and Industry; Draft Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2017-D-6580 |
| Posted | Oct 25, 2019 |
| Comment period opens | Oct 25, 2019 |
| Comments due | May 24, 2020 |
At a glance
- No Open for comment
- 1,000+ Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: